About 4th Global Pharmacovigilance Congress 2026
The 4th Global Pharmacovigilance Congress 2026 (GPC 2026) is a premier international platform dedicated to advancing drug safety, patient protection, and regulatory excellence across the pharmaceutical, biotechnology, medical device, and healthcare sectors.
As the healthcare ecosystem rapidly evolves—with novel therapies, real-world evidence, AI-driven safety systems, and increasingly complex regulatory expectations—pharmacovigilance has become a strategic cornerstone of public health. GPC 2026 brings together global experts to address these challenges and shape the future of safety surveillance.
Vision
To foster a globally harmonized pharmacovigilance ecosystem that ensures safe, effective, and high-quality medicinesthroughout their lifecycle while strengthening patient trust and regulatory compliance worldwide.
Mission
- To provide a knowledge-driven forum for sharing best practices, innovations, and regulatory insights in pharmacovigilance
- To bridge industry, regulators, academia, and technology providers through meaningful collaboration
- To support the adoption of robust, compliant, and future-ready drug safety systems
- To empower professionals with practical strategies for risk management, benefit–risk assessment, and patient safety
Why Attend 4th GPC 2026?
The 4th Global Pharmacovigilance Congress 2026 is designed to deliver real-world value through expert-led discussions, case studies, and interactive sessions.
Participants will gain insights into:
- Global pharmacovigilance regulations and evolving expectations
- Signal detection, risk management plans (RMPs), and benefit–risk evaluation
- Pharmacovigilance inspections, audits, and compliance readiness
- Integration of AI, automation, and real-world data in drug safety
- Post-marketing surveillance, patient safety programs, and quality systems
- Emerging challenges in biologics, biosimilars, vaccines, and medical devices
Who Should Attend?
4th GPC 2026 is tailored for professionals involved in drug safety and regulatory oversight, including:
- Pharmacovigilance & Drug Safety Professionals
- Regulatory Affairs & Compliance Teams
- Clinical Research & Medical Affairs Experts
- Quality Assurance & Audit Professionals
- CROs, PV Service Providers, and Technology Vendors
- Academicians, Researchers, and Students
- Regulatory Authority Representatives
What Makes 4th GPC 2026 Unique?
- Global perspective with participation from international experts and thought leaders
- Practice-oriented sessions featuring real regulatory case studies
- Interactive formats including panel discussions, workshops, and Q&A forums
- Networking opportunities with decision-makers and innovators
- Future-focused agenda addressing digital transformation and next-generation PV systems
Building the Future of Patient Safety
The 4th Global Pharmacovigilance Congress 2026 is more than a conference—it is a collaborative movement to strengthen pharmacovigilance systems worldwide. By fostering dialogue, innovation, and shared learning, GPC 2026 aims to contribute meaningfully to global patient safety and public health outcomes.
Join us in shaping the future of pharmacovigilance.
